Clinical Trial Update: Evaluate the Efficacy &Safety of Methylphenidate Transdermal System (MTS) in Adolescents Aged 13-17 Years With ADHD [Phase 3]

View source ↗

Summary

Phase 3 trial completed evaluating the efficacy and safety of the methylphenidate transdermal system (MTS) in adolescents aged 13-17 with ADHD; results have bee…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder

Drugs mentioned

• Methylphenidate Transdermal System (methylphenidate)

Snippet

Sponsor: Noven Therapeutics | Conditions: ADHD | Phase 3 | Status: COMPLETED | Results posted: 2009-06-11